Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Laquinimod decreases Bax expression and reduces caspase-6 activation in neurons.
Monozygotic twins discordant for narcolepsy type 1 and multiple sclerosis.
Mass Spectrometry-Based Quantitative Strategies for Assessing the Biological Consequences and Repair of DNA Adducts.
Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation.
Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab.
Ischemia/reperfusion injury in vascularized tissue allotransplantation: tissue damage and clinical relevance.
[Clinical and demographic characteristics of patients with multiple sclerosis].
Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
The effects of progressive muscular relaxation as a nursing procedure used for those who suffer from stress due to multiple sclerosis.
Involvement of the optic nerve in mutated CSF1R-induced hereditary diffuse leukoencephalopathy with axonal spheroids.
Merging Transport Data for Choroid Plexus with Blood-Brain Barrier to Model CNS Homeostasis and Diseases More Effectively.
Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.
Poster 353 Acute Onset Chronic Inflammatory Demyelinating Polyneuropathy (A-CIDP) with CNS Involvement Initially Diagnosed as Guillain-Barre Syndrome (GBS): A Case Report.
Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression.
Response on Paraparetic Guillain-Barré syndrome: non-demyelinating reversible conduction failure restricted to the lower limbs.
Comment on Paraparetic Guillain-Barré syndrome: non-demyelinating reversible conduction failure restricted to the lower limbs.
Pathophysiology, assessment and management of multiple sclerosis fatigue: an update.
Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy.
Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G.
Partial MHC class II constructs as novel immunomodulatory therapy for stroke.
Hemiplegic Migraine Presenting with Prolonged Somnolence: A Case Report.
Docosahexaenoic Acid Reduces Cerebral Damage and Ameliorates Long-Term Cognitive Impairments Caused by Neonatal Hypoxia-Ischemia in Rats.
[Anesthesia and Multiple Sclerosis: What needs to be considered?].
Neurosarcoidosis in Pediatric Patients: A Case Report and Review of Isolated and Systemic Neurosarcoidosis.
Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica.

Pages